SFM
ECYT

Signet Financial Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Signet Financial Management’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,931
Closed -$34K – 967
2018
Q3 		$34K Buy
1,931
+1,126
+140% +$19.3K 0.01% 447
2018
Q2 		$11K Buy
+805
New +$9.55K ﹤0.01% 620

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Signet Financial Management's ECYT Position: Q4 2018 in Review

Signet Financial Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 1,931 shares — an estimated $34K sold.

Signet Financial Management first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $34K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Signet Financial Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Signet Financial Management sold 1,931 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $34K.
  • Signet Financial Management first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Signet Financial Management's Endocyte, Inc. Common Stock position peaked at $34K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Signet Financial Management's 13F filing for Q4 2018, filed 14 Feb 2019.